IBDEI0F7 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7347,0)
 ;;=528.2^^55^579^43
 ;;^UTILITY(U,$J,358.3,7347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7347,1,4,0)
 ;;=4^528.2
 ;;^UTILITY(U,$J,358.3,7347,1,5,0)
 ;;=5^Oral Aphthae
 ;;^UTILITY(U,$J,358.3,7347,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,7348,0)
 ;;=692.72^^55^579^44
 ;;^UTILITY(U,$J,358.3,7348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7348,1,4,0)
 ;;=4^692.72
 ;;^UTILITY(U,$J,358.3,7348,1,5,0)
 ;;=5^Photosensitivity
 ;;^UTILITY(U,$J,358.3,7348,2)
 ;;=^93951
 ;;^UTILITY(U,$J,358.3,7349,0)
 ;;=692.6^^55^579^46
 ;;^UTILITY(U,$J,358.3,7349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7349,1,4,0)
 ;;=4^692.6
 ;;^UTILITY(U,$J,358.3,7349,1,5,0)
 ;;=5^Poison Ivy
 ;;^UTILITY(U,$J,358.3,7349,2)
 ;;=^271908
 ;;^UTILITY(U,$J,358.3,7350,0)
 ;;=698.0^^55^579^54
 ;;^UTILITY(U,$J,358.3,7350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7350,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,7350,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,7350,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,7351,0)
 ;;=698.9^^55^579^53
 ;;^UTILITY(U,$J,358.3,7351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7351,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,7351,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,7351,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,7352,0)
 ;;=696.1^^55^579^55
 ;;^UTILITY(U,$J,358.3,7352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7352,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,7352,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,7352,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,7353,0)
 ;;=287.0^^55^579^56
 ;;^UTILITY(U,$J,358.3,7353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7353,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,7353,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,7353,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,7354,0)
 ;;=782.1^^55^579^57
 ;;^UTILITY(U,$J,358.3,7354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7354,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,7354,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,7354,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,7355,0)
 ;;=706.2^^55^579^61
 ;;^UTILITY(U,$J,358.3,7355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7355,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,7355,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,7355,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,7356,0)
 ;;=690.10^^55^579^64
 ;;^UTILITY(U,$J,358.3,7356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7356,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,7356,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,7356,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,7357,0)
 ;;=702.11^^55^579^62
 ;;^UTILITY(U,$J,358.3,7357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7357,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,7357,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,7357,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,7358,0)
 ;;=702.19^^55^579^63
 ;;^UTILITY(U,$J,358.3,7358,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7358,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,7358,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,7358,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,7359,0)
 ;;=686.9^^55^579^65
 ;;^UTILITY(U,$J,358.3,7359,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7359,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,7359,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,7359,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,7360,0)
 ;;=708.9^^55^579^78
 ;;^UTILITY(U,$J,358.3,7360,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7360,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,7360,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;^UTILITY(U,$J,358.3,7360,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,7361,0)
 ;;=078.10^^55^579^79
